BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11000921)

  • 1. Diagnostic subgroups within a sample of comorbid substance abusers: correlates and characteristics.
    Toneatto T; Negrete JC; Calderwood K
    Am J Addict; 2000; 9(3):253-64. PubMed ID: 11000921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining subgroups of dual diagnosis patients for service planning.
    Lehman AF; Myers CP; Dixon LB; Johnson JL
    Hosp Community Psychiatry; 1994 Jun; 45(6):556-61. PubMed ID: 8088734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What characterizes substance abusers who commit suicide attempts? Factors related to Axis I disorders and patterns of substance use disorders. A study of treatment-seeking substance abusers in Norway.
    Landheim AS; Bakken K; Vaglum P
    Eur Addict Res; 2006; 12(2):102-8. PubMed ID: 16543746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A; Giannuzzi R; Sollazzo F; Petrongolo L; Bernardini L; Dain S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and patterns of "dual diagnosis" among psychiatric inpatients.
    Lehman AF; Myers CP; Corty E; Thompson JW
    Compr Psychiatry; 1994; 35(2):106-12. PubMed ID: 8187473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients.
    Havassy BE; Arns PG
    Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical diagnosis of substance use disorders in private psychiatric populations.
    Miller NS; Belkin BM; Gibbons R
    J Subst Abuse Treat; 1994; 11(4):387-92. PubMed ID: 7966510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity in a clinical sample of substance abusers.
    Skinstad AH; Swain A
    Am J Drug Alcohol Abuse; 2001 Feb; 27(1):45-64. PubMed ID: 11373036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of improvement in quality of life of severely mentally ill substance abusers during 18 months of co-operation between psychiatric and social services.
    Schaar I; Ojehagen A
    Soc Psychiatry Psychiatr Epidemiol; 2003 Feb; 38(2):83-7. PubMed ID: 12563550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients.
    Bakken K; Landheim AS; Vaglum P
    BMC Psychiatry; 2007 Jun; 7():29. PubMed ID: 17594479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence.
    Busto UE; Romach MK; Sellers EM
    J Clin Psychopharmacol; 1996 Feb; 16(1):51-7. PubMed ID: 8834419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation efforts among substance abusers with and without psychiatric comorbidity.
    Unrod M; Cook T; Myers MG; Brown SA
    Addict Behav; 2004 Jul; 29(5):1009-13. PubMed ID: 15219350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ; Muzinić L; Radeljak S
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity of psychiatric and substance use disorders in late adolescence: a cluster analytic approach.
    Beitchman JH; Adlaf EM; Douglas L; Atkinson L; Young A; Johnson CJ; Escobar M; Wilson B
    Am J Drug Alcohol Abuse; 2001 Aug; 27(3):421-40. PubMed ID: 11506260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of clinical diagnoses for comorbidity studies in substance use disorders.
    Torrens M; Martin-Santos R; Samet S
    Neurotox Res; 2006 Dec; 10(3-4):253-61. PubMed ID: 17197374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity of mood and substance use disorders in patients with binge-eating disorder: Associations with personality disorder and eating disorder pathology.
    Becker DF; Grilo CM
    J Psychosom Res; 2015 Aug; 79(2):159-64. PubMed ID: 25700727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients.
    Cacciola JS; Alterman AI; Rutherford MJ; McKay JR; Mulvaney FD
    Drug Alcohol Depend; 2001 Feb; 61(3):271-80. PubMed ID: 11164691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.